Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Skin Elements Limited ( (AU:SKN) ) has shared an announcement.
Skin Elements Limited has secured $2.5 million through a two-tranche placement at $0.002 per share, with additional options, to fund the commercialization of its SE Formula biotechnology. This capital injection, managed by 62 Capital Pty Ltd, will support the company’s transition into commercial revenue programs, although it will result in a 64% dilution of current shareholders’ holdings.
More about Skin Elements Limited
Skin Elements Limited operates in the biotechnology industry, focusing on all-natural antimicrobial biotechnology. The company’s primary products include the SE Formula, Soleo Organics sunscreen, PapayaActivs therapeutic skincare, SuprCuvr disinfectant, and ECO-Nurture agriculture biostimulant, targeting personal protection and agricultural markets.
Current Market Cap: A$3.15M
For detailed information about SKN stock, go to TipRanks’ Stock Analysis page.